반응식
[CH2:1]([OH:4])[CH:2]=[CH2:3].F[C:6]1[CH:7]=[C:8]([CH3:15])[CH:9]=[CH:10][C:11]=1[N+:12]([O-:14])=[O:13].[CH3:16][C:17]1[CH:23]=[CH:22][C:20]([NH2:21])=[C:19]([O:24][CH2:25][CH:26]=[CH2:27])[CH:18]=1.CC1C=CC(N)=[C:31]([O:36]CC(C)C)C=1.[NH2:41][C:42]1[S:43][CH:44]=[CH:45][N:46]=1>>[CH2:1]([O:4][C:6]1[CH:7]=[C:8]([CH3:15])[CH:9]=[CH:10][C:11]=1[N+:12]([O-:14])=[O:13])[CH:2]=[CH2:3].[CH2:25]([O:24][C:19]1[CH:18]=[C:17]([CH3:16])[CH:23]=[CH:22][C:20]=1[NH:21][C:31]([NH:41][C:42]1[S:43][CH:44]=[CH:45][N:46]=1)=[O:36])[CH:26]=[CH2:27]참가 물질
7
반응물 5
생성물 2
실험 절차
3-Allyloxy-4-nitrotoluene (0.67 g, 70%) was prepared from allyl alcohol and 3-fluoro-4-nitrotoluene (0.77 g, 5.0 mmol) following the general procedure G. This was reduced to 4-methyl-2-(allyloxy)aniline (0.40 g, 70%) following general procedure B. 1-(2-Allyloxy-4-methyl-phenyl)-3-thiazol-2-yl-urea (196 mg, 68%) was prepared from 4-methyl-2-(2-methylpropoxy)aniline (163 mg, 1.0 mmol) and 2-aminothiazole (100 mg, 1.0 mmol) following the general procedure D.
출처 및 근거
- ORD 기록
- ord-f3f00402cd1a427ca393ea3aae9f113a
- 출처 데이터셋
- uspto-grants-2011_11
- 특허 번호
- US08063081B2
연결된 노트
불러오는 중…